Highlights
- Up to 30,000 participants will be included in the trial
- They expect to submit it for final regulatory review by October, if successful
Pfizer and BioNTech began their late-stage human trial for a potential corona virus vaccine. The respective U.S. drug maker and German biotech companies said the same on Monday. The pharmaceutical companies race to win regulatory approva....
Tags : COVID - 19 Pandemic, Corona virus cases, Corona virus vaccine, Pfizer, BioNTech,
comments (0)